Optic neuritis: Prognosis for multiple sclerosis from MRI, CSF, and HLA findings

Neurology

Volumn 50, Issue 3, 1998, Pages 708-714

  Soderstrom M ^a   Ya Ping, Jin ^a   Hillert, J ^a   Link, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0345628025     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.3.708     Document Type: Article

References (35)

1. Matthews WB. Symptoms and signs. In: Matthews WB, ed. McAlpine's multiple sclerosis. Edinburgh: Churchill Livingstone, 1991:43-47.
2. Francis DA, Compston DAS, Batchelor JR, McDonald WI. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow up. J Neurol Neurosurg Psychiatry 1987;50:758-765.
3. Rizzo JF, Lessell S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology 1988;38:185-190.
4. Morrissey SP, Miller DH, Kendall BE, et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain 1993;116:135-146.
5. Beck RW, Cleary PA, Trobe JD, et al., and the Optic Neuritis Study Group. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 1993;329:1764-1769.
6. Frederiksen JL, Larsson HBW, Olesen J. Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritis. Acta Neurol Scand 1992;86:317-322.
7. Söderström M. The clinical and paraclinical profile of optic neuritis: a prospective study. Ital J Neurol Sci 1995;16:167-176.
8. Andersson M, Alvarez-Cermeno J, Bernadi G, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 1994;57:897-902.
9. Söderström M, Lindqvist M, Hillert J, Käll T-B, Link H. Optic neuritis: findings on MRI, CSF examination and HLA class II typing in 60 patients and results of a short-term follow-up. J Neurol 1994;241:391-397.
10. Perkin GD, Rose FC. Optic neuritis and its differential diagnosis. Oxford: Oxford University Press, 1979.
11. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
12. Sörnäs R. A new method for cytological examination of cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1967;30:568-577.
13. Link H, Tibbling G. Principles of albumin and IgG analyses in neurological disorders. II. Influence of serum concentration on CSF and evaluation of blood-brain barrier damage. Scand J Clin Lab Invest 1977;37:391-396.
14. Tibbling G, Link H, Öhman S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977;37:385-390.
15. Olsson T, Kostulas V, Link H. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double antibody peroxidase labeling, and avidinbiotin amplification. Clin Chem 1984;30:1246-1249.
16. Carlsson B, Wallin J, Böhme J, Möller E. HLA-DR-DQ haplotypes defined by restriction fragment length analysis: correlation to serology. Hum Immunol 1987;20:95-113.
17. Olerup O, Zetterquist H. DR "low-resolution" PCR-SSP typing: a correction and update. Tissue Antigens 1993;41:55-56. Letter.
18. Paty DW, Oger JJF, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoced potentials, oligoclonal banding and CT. Neurology 1988;38:180-185.
19. Lee KH, Hashimoto SA, Hooge JP, et al. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a psospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology 1991;41:657-660.
20. Rolak LA, Beck RW, Paty DW, et al, and the Optic Neuritis Study Group. Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial. Neurology 1996;46: 368-372.
21. Nikoskelainen E, Frey H, Salmi A. Prognosis of optic neuritis with special reference to cerebrospinal fluid immunoglobulins and measles virus antibodies. Ann Neurol 1981;9:545-550.
22. Sandberg-Wollheim M, Bynke H, Cronqvist S, Holtås S, Platz P, Ryder LP. A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 1990;27:386-393.
23. Martinelli V, Comi G, Filippi M, et al. Paraclinical tests in acute-onset optic neuritis: basal data and results of a short follow-up. Acta Neurol Scand 1991;84:231-236.
24. Fillipini G, Comi G, Cosi V, et al. Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis. J Neurol 1994;241:132-137.
25. Ormerod IEC, McDonald WI, Du Boulay GH, et al. Disseminated lesions at presentation in patients with optic neuritis. J Neurol Neurosurg Psychiatry 1986;49:124-127.
26. Beck RW, Arrington J, Murtagh FR, Cleary PA, Kaufman DI, and the Optic Neuritis Study Group. Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group. Arch Ophthalmol 1993;50:841-846.
27. Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993;43:2632-2637.
28. Tas MW, Barkhol F, van Walderveen AA, Polman CH, Hommes OR, Valk J. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. Am J Neuroradiol 1995;16:259-264.
29. Link H. The cerebrospinal fluid in multiple sclerosis. In: Swash M, Oxbury J, eds. Clinical neurology. Edinburgh: Churchill Livingstone, 1991:1128-1138.
30. Rudick RA, Schiffer RB, Schwetz KM, Herndon RM. Multiple sclerosis: the problem of incorrect diagnosis. Arch Neurol 1986;43:578-583.
31. Fieschi C, Gasperini C, Ristori G, et al. Patients with clinically definite multiple sclerosis, white matter abnormalities on MRI, and normal CSF: if not multiple sclerosis, what is it? J Neurol Neurosurg Psychiatry 1995;58:255-256. Letter.
32. Zeman AZJ, Kidd D, McLean BN, et al. A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;60:27-30.
33. Hillert J, Käll T, Olerup O, Söderström M. Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity. Acta Neurol Scand 1996;94:161-166.
34. Hely MA, McManis PG, Doran TJ, Walsh JC, McLeod JG. Acute optic neuritis: a prospective study of risk factors for multiple sclerosis. J Neurol Neurosurg Psychiatry 1986;49: 1125-1130.
35. Kelly MA, Cavan DA, Penny MA, et al. The influence of HLA-DR and -DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome. Hum Immunol 1993; 37:185-191.